- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/30 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 263/30
Total number of patents in this class: 75
10-year publication summary
|
4
|
6
|
5
|
2
|
5
|
1
|
2
|
2
|
6
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cumberland Pharmaceuticals Inc. | 74 |
6 |
| Vanderbilt University | 2034 |
6 |
| Toray Industries, Inc. | 7161 |
5 |
| Bristol-myers Squibb Company | 4747 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Boehringer Ingelheim International GmbH | 4491 |
3 |
| Anima Biotech Inc. | 39 |
3 |
| The Regents of the University of California | 20960 |
2 |
| Allergan, Inc. | 2145 |
2 |
| ChemoCentryx, Inc. | 361 |
2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 787 |
2 |
| Dompé Farmaceutici S.p.A. | 305 |
2 |
| Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 143 |
2 |
| Corteva Agriscience LLC | 2646 |
2 |
| Merck Sharp & Dohme LLC | 3734 |
2 |
| Amgen Inc. | 4483 |
1 |
| FUJIFILM Corporation | 30808 |
1 |
| The General Hospital Corporation | 4900 |
1 |
| The Trustees of Columbia University in the City of New York | 3663 |
1 |
| Mayo Foundation for Medical Education and Research | 3423 |
1 |
| Other owners | 24 |